Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954004 · ClinicalTrials.gov registry record
Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients
A clinical trial, sponsored by Myriad Genetic Laboratories.
- Completed
- Registry status
- 1,270
- Enrollment target
NCT01954004: Completed study, sponsored by Myriad Genetic Laboratories.
NCT01954004 is a clinical trial that has completed, run by Myriad Genetic Laboratories. The registered enrollment target is 1,270 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01954004 has completed, sponsored by Myriad Genetic Laboratories.
- COMPLETED
- Registry status
- 1,270 participants
- Enrollment target
Study Summary
This registry is intended to evaluate the impact of genomic test results towards selecting a first-line therapy option for newly diagnosed localized prostate cancer patients.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,270 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01954004
The ClinicalTrials.gov registry entry for NCT01954004 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Myriad Genetic Laboratories, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01954004 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01954004 about?
NCT01954004 is a clinical study titled "Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients". This registry is intended to evaluate the impact of genomic test results towards selecting a first-line therapy option for newly diagnosed localized prostate cancer patients.
What is the current status of trial NCT01954004?
This trial is currently completed. The enrollment target is 1,270 participants. The study started on 2013-04. Estimated completion is 2014-09.
Who is sponsoring clinical trial NCT01954004?
This trial is sponsored by Myriad Genetic Laboratories, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.